BusinessOncoMed Pharmaceuticals Announces Fourth Quarter and Full Year 2016 Financial ResultsBy Nasdaq OMXMar 8, 2017, 9:06 PM UTC
BusinessOncoMed Pharmaceuticals Announces Fourth Quarter and Full Year 2016 Financial ResultsBy Nasdaq OMXMar 8, 2017, 9:06 PM UTC
BusinessOncoMed Announces Year-End Cash Balance and 2017 OutlookBy Nasdaq OMXJan 5, 2017, 1:31 PM UTC
BusinessOncoMed Announces Year-End Cash Balance and 2017 OutlookBy Nasdaq OMXJan 5, 2017, 1:31 PM UTC
BusinessOncoMed Pharmaceuticals Appoints Perry Karsen to Board of DirectorsBy Nasdaq OMXJan 6, 2016, 1:30 PM UTC